About LIfT Biosciences
LIfT Biosciences is a company based in London (United Kingdom) founded in 2016.. LIfT Biosciences has raised $20.13 million across 9 funding rounds from investors including LIfT Biosciences, Downing and EIT Health. The company has 8 employees as of December 31, 2022. LIfT Biosciences offers products and services including IMANs. LIfT Biosciences operates in a competitive market with competitors including Caribou Biosciences, Senti Biosciences, Immunocore, Achilles Therapeutics and Kite Pharma, among others.
- Headquarter London, United Kingdom
- Employees 8 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lift Biosciences Limited
- Date of Incorporation 23 Oct, 2014
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.13 M (USD)
in 9 rounds
-
Latest Funding Round
$14 M (USD), Grant
Jul 29, 2025
-
Investors
LIfT Biosciences
& 11 more
-
Employee Count
8
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LIfT Biosciences
LIfT Biosciences offers a comprehensive portfolio of products and services, including IMANs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cells designed to kill cancer and modulate immune system for tumor targeting.
Unlock access to complete
Funding Insights of LIfT Biosciences
LIfT Biosciences has successfully raised a total of $20.13M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $14 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $14.0M
- First Round First Round
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Grant - LIfT Biosciences | Valuation |
investors |
|
| Sep, 2024 | Amount | Series A - LIfT Biosciences | Valuation | LifeSpan Vision Ventures , Sijbrandij Foundation | |
| May, 2024 | Amount | Grant - LIfT Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LIfT Biosciences
LIfT Biosciences has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LIfT Biosciences, Downing and EIT Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Seed and early-stage German tech and biotech investments are conducted.
|
Founded Year | Domain | Location | |
|
Inheritance tax relief, funds, and bonds are provided across sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LIfT Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LIfT Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lift Biosciences Comparisons
Competitors of LIfT Biosciences
LIfT Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caribou Biosciences, Senti Biosciences, Immunocore, Achilles Therapeutics and Kite Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
T-cell therapies targeting tumor neo-antigens for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Cancer immunotherapy products are developed using genetic engineering.
|
|
| domain | founded_year | HQ Location |
Cell-based therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lift Biosciences
Frequently Asked Questions about LIfT Biosciences
When was LIfT Biosciences founded?
LIfT Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is LIfT Biosciences located?
LIfT Biosciences is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is LIfT Biosciences a funded company?
LIfT Biosciences is a funded company, having raised a total of $20.13M across 9 funding rounds to date. The company's 1st funding round was a Grant of $1M, raised on May 24, 2018.
How many employees does LIfT Biosciences have?
As of Dec 31, 2022, the latest employee count at LIfT Biosciences is 8.
What does LIfT Biosciences do?
LIfT Biosciences was founded in 2016 in London, United Kingdom, within the biotechnology sector. Neutrophil-based cell therapies are developed using an allogeneic innate immune-cell platform known as Neutrophil only leukocyte infusion therapy (N-LIfT). Immunomodulatory alpha neutrophils (IMANs) are produced at scale from induced pluripotent stem cells (iPSCs) to address solid tumors, autoimmune diseases, neurological conditions, and antimicrobial resistance.
Who are the top competitors of LIfT Biosciences?
LIfT Biosciences's top competitors include Immunocore, Achilles Therapeutics and Autolus.
What products or services does LIfT Biosciences offer?
LIfT Biosciences offers IMANs.
Who are LIfT Biosciences's investors?
LIfT Biosciences has 12 investors. Key investors include LIfT Biosciences, Downing, EIT Health, UK Research and Innovation, and Sijbrandij Foundation.